Is this a piece of news regarding world politics, sports, business, or science and technology?
OSI stock falters on Tarceva sales concerns Shares of OSI Pharmaceuticals Inc. fell sharply Friday on concerns about the newly approved drug #39;s ability to meet sales targets. 
